Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study

被引:5
|
作者
Gao, Fei [1 ]
Liu, Xiaoxue [2 ]
Wang, Xizhu [2 ]
Chen, Shouhua [3 ]
Shi, Jihong [4 ]
Zhang, Ying [5 ]
Wu, Shouling [4 ]
Cai, Jun [6 ,7 ]
机构
[1] Univ Hong Kong, LKS Fac Med, Dept Opthalmol, Hong Kong, Hong Kong, Peoples R China
[2] North China Univ Sci & Technol, Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China
[3] North China Univ Sci & Technol, Kailuan Hosp, Dept Hlth Care Ctr, Tangshan, Peoples R China
[4] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China
[5] North China Univ Sci & Technol, Hosp, Dept Ultrasonog, Tangshan, Peoples R China
[6] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China
[7] Peking Union Med Coll, Beijing, Peoples R China
来源
PLOS ONE | 2016年 / 11卷 / 07期
关键词
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; ASSOCIATION; PREVALENCE; INFLAMMATION; POPULATION; MORTALITY; METRICS; IMPACT;
D O I
10.1371/journal.pone.0158869
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
American Heart Association cardiovascular health metrics are intimately related to cardiovascular diseases. Acting as a key independent risk factor for high morbidity and mortality of cardiovascular diseases, hypertension and its relationship between health status get urgent attention. While the influence of individual health status changes and the future risk of new-onset hypertension is rarely understood, the present study applied this construct to assess the changes of cardiovascular health status and the morbidity of hypertension in Kailuan cohort study in north China. The Cardiovascular Health Score (CHS) was evaluated by the follow-ups of 2006-2007, 2008-2009, 2010-2011 and 2012-2013. The study population (n = 19381) was divided into 5 groups based on the changes in their CHS score between the first two follow-ups (Delta CHS) of 2006-2007 and 2008-2009 (<=-2, -1, 0, 1, >= 2). The morbidity of hypertension was collected during 2010-2011 and 2012-2013 follow-ups. Data analysis showed that during a median follow-up of 3.79 +/- 0.96 years, morbidity of hypertension had a graded relationship with Delta CHS. As Delta CHS scored from low to high, the standardized morbidity of hypertension for all participants were 81.40, 75.47, 68.37, 71.43 and 83.13 per 1000 person-year, respectively. An increased Delta CHS score of 1 was associated with a 10% decrease in the future risk of new-onset hypertension(HR: 0.90, 95% CI: 0.88-0.92). In conclusion, there was a strong inverse relationship between the incidence of new-onset hypertension and elevation of cardiovascular health metrics. Population-wide prevention, especially the promotion of lifestyle improvements, is critical to reducing the morbidity of new-onset hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes: The Kailuan prospective study
    Liu, Xiaoxue
    Shi, Jihong
    Wang, Anxin
    Song, Qiaofeng
    Huang, Zhe
    Zhu, Chenrui
    Du, Xin
    Zhang, Ying
    Chen, Shuohua
    Wang, Xizhu
    Wu, Shouling
    MEDICINE, 2016, 95 (34)
  • [2] Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: insights from the Kailuan cohort
    Wu, Shouling
    Wang, Yanxiu
    Wang, Jiangshui
    Feng, Jun
    Li, Furong
    Lin, Liming
    Ruan, Chunyu
    Nie, Zhifang
    Tian, Jinwei
    Jin, Cheng
    BMC MEDICINE, 2025, 23 (01):
  • [3] Arterial stiffness and risk of new-onset fragility fracture in Chinese men and women: The Kailuan cohort study
    Guo, Lu
    Zhang, Nan
    Zhang, Yimeng
    Xing, Lei
    Xu, Wenqi
    Li, Wenjuan
    Zhang, Lisha
    Hou, Xiaoli
    Chen, Shuohua
    Wu, Shouling
    Tian, Faming
    BONE, 2024, 180
  • [4] Proteinuria and risk of stroke in patients with hypertension: The Kailuan cohort study
    Wang, Anxin
    Dai, Liye
    Su, Zhaoping
    Chen, Shuohua
    Li, Junjuan
    Wu, Shouling
    Wang, Yongjun
    Wang, Yilong
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (04): : 765 - 774
  • [5] Risk of new-onset and prevalent disease in chronic rhinosinusitis: A prospective cohort study
    Hirsch, Annemarie G.
    Schwartz, Brian S.
    Nordberg, Cara
    Tan, Bruce K.
    Schleimer, Robert P.
    Kern, Robert C.
    Peters, Anju T.
    Bandeen-Roche, Karen
    Lehmann, Ashton E.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2023, 13 (09) : 1715 - 1725
  • [6] Joint effect of elevated-c-reactive protein level and hypertension on new-onset stroke: A nationwide prospective cohort study of CHARLS
    Chen, Xuanli
    Liu, Siyuan
    Chu, Jiadong
    Hu, Wei
    Sun, Na
    Shen, Yueping
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [7] Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study
    Ramezankhani, Azra
    Azizi, Fereidoun
    Hadaegh, Farzad
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [8] The relationship between lipid risk score and new-onset hypertension in a prospective cohort study
    Xie, Hankun
    Zhuang, Qian
    Mu, Jialing
    Sun, Junxiang
    Wei, Pengfei
    Zhao, Xianghai
    Chen, Yanchun
    Dong, Jiayi
    Chen, Changying
    Wei, Lai
    Yin, Yunjie
    Yang, Song
    Shen, Chong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Plasma Calprotectin Levels Associate With New-Onset Hypertension in the General Population: A Prospective Cohort Study
    Bourgonje, Arno R.
    Bourgonje, Martin F.
    la Bastide-van Gemert, Sacha
    Nilsen, Tom
    Hidden, Clara
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    Mulder, Douwe J.
    Dullaart, Robin P. F.
    Abdulle, Amaal E.
    van Goor, Harry
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (01):
  • [10] Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension A retrospective cohort study
    Feng, Yuanyuan
    Kang, Kai
    Xue, Qiqi
    Chen, Yafen
    Wang, Wei
    Cao, Jiumei
    MEDICINE, 2020, 99 (34) : E21541